Edwards CM - Search Results

1

Novel therapeutic targets in myeloma bone disease.

Webb SL, Edwards CM. Webb SL, et al. Among authors: edwards cm. Br J Pharmacol. 2014 Aug;171(16):3765-76. doi: 10.1111/bph.12742. Br J Pharmacol. 2014. PMID: 24750110 Free PMC article. Review.

2

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Edwards CM, Mueller G, Roelofs AJ, Chantry A, Perry M, Russell RG, Van Camp B, Guyon-Gellin Y, Niesor EJ, Bentzen CL, Vanderkerken K, Croucher PI. Edwards CM, et al. Int J Cancer. 2007 Apr 15;120(8):1657-63. doi: 10.1002/ijc.22478. Int J Cancer. 2007. PMID: 17230522

3

BTK inhibition in myeloma: targeting the seed and the soil.

Edwards CM. Edwards CM. Blood. 2012 Aug 30;120(9):1757-9. doi: 10.1182/blood-2012-07-439216. Blood. 2012. PMID: 22936735 Free article. No abstract available.

4

Contributions of the host microenvironment to cancer-induced bone disease.

Olechnowicz SW, Edwards CM. Olechnowicz SW, et al. Among authors: edwards cm. Cancer Res. 2014 Mar 15;74(6):1625-31. doi: 10.1158/0008-5472.CAN-13-2645. Epub 2014 Mar 5. Cancer Res. 2014. PMID: 24599133 Free PMC article. Review.

5

Preclinical animal models of multiple myeloma.

Lwin ST, Edwards CM, Silbermann R. Lwin ST, et al. Among authors: edwards cm. Bonekey Rep. 2016 Feb 3;5:772. doi: 10.1038/bonekey.2015.142. eCollection 2016. Bonekey Rep. 2016. PMID: 26909147 Free PMC article.

6

New approaches to targeting the bone marrow microenvironment in multiple myeloma.

Gooding S, Edwards CM. Gooding S, et al. Among authors: edwards cm. Curr Opin Pharmacol. 2016 Jun;28:43-9. doi: 10.1016/j.coph.2016.02.013. Epub 2016 Mar 23. Curr Opin Pharmacol. 2016. PMID: 27018230 Review.

7

The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.

Turner CJ, Edwards CM. Turner CJ, et al. Among authors: edwards cm. Curr Osteoporos Rep. 2016 Oct;14(5):170-7. doi: 10.1007/s11914-016-0323-2. Curr Osteoporos Rep. 2016. PMID: 27566487 Review.

8

A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.

Lwin ST, Fowler JA, Drake MT, Edwards JR, Lynch CC, Edwards CM. Lwin ST, et al. Among authors: edwards cm, edwards jr. Mol Cancer. 2017 Feb 28;16(1):49. doi: 10.1186/s12943-017-0616-9. Mol Cancer. 2017. PMID: 28241871 Free PMC article.

9

Bone marrow adiposity and multiple myeloma.

Morris EV, Edwards CM. Morris EV, et al. Among authors: edwards cm. Bone. 2019 Jan;118:42-46. doi: 10.1016/j.bone.2018.03.011. Epub 2018 Mar 13. Bone. 2019. PMID: 29548987 Review.

10

Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma.

Morris EV, Edwards CM. Morris EV, et al. Among authors: edwards cm. J Cell Physiol. 2018 Dec;233(12):9159-9166. doi: 10.1002/jcp.26884. Epub 2018 Jun 26. J Cell Physiol. 2018. PMID: 29943829 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters